{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T11:41:40Z","timestamp":1792755700850,"version":"4.5.0"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T00:00:00Z","timestamp":1631836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Ferroptosis is an iron-dependent cell death process that plays important regulatory roles in the occurrence and development of cancers, including hepatocellular carcinoma (HCC). Moreover, the molecular events surrounding aberrantly expressed long non-coding RNAs (lncRNAs) that drive HCC initiation and progression have attracted increasing attention. However, research on ferroptosis-related lncRNA prognostic signature in patients with HCC is still lacking. In this study, the association between differentially expressed lncRNAs and ferroptosis-related genes, in 374 HCC and 50 normal hepatic samples obtained from The Cancer Genome Atlas (TCGA), was evaluated using Pearson\u2019s test, thereby identifying 24 ferroptosis-related differentially expressed lncRNAs. The least absolute shrinkage and selection operator (LASSO) algorithm and Cox regression model were used to construct and validate a prognostic risk score model from both TCGA training dataset and GEO testing dataset (GSE40144). A nine-lncRNA-based signature (CTD-2033A16.3, CTD-2116N20.1, CTD-2510F5.4, DDX11-AS1, LINC00942, LINC01224, LINC01231, LINC01508, and ZFPM2-AS1) was identified as the ferroptosis-related prognostic model for HCC, independent of multiple clinicopathological parameters. In addition, the HCC patients were divided into high-risk and low-risk groups according to the nine-lncRNA prognostic signature. The gene set enrichment analysis enrichment analysis revealed that the lncRNA-based signature might regulate the HCC immune microenvironment by interfering with tumor necrosis factor \u03b1\/nuclear factor kappa-B, interleukin 2\/signal transducers and activators of transcription 5, and cytokine\/cytokine receptor signaling pathways. The infiltrating immune cell subtypes, such as resting memory CD4(+) T cells, follicular helper T cells, regulatory T cells, and M0 macrophages, were all significantly different between the high-risk group and the low-risk group as indicated in Spearman\u2019s correlation analysis. Moreover, a substantial increase in the expression of B7H3 immune checkpoint molecule was found in the high-risk group. Our findings provided a promising insight into ferroptosis-related lncRNAs in HCC and a personalized prediction tool for prognosis and immune responses in patients.<\/jats:p>","DOI":"10.3389\/fimmu.2021.719175","type":"journal-article","created":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T04:38:07Z","timestamp":1631853487000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":152,"title":["Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma"],"prefix":"10.3389","volume":"12","author":[{"given":"Zhijie","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bi","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuju","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangshuang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kewa","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoli","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhicheng","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanliang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,9,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.589908","article-title":"Hepatocellular Senescence: Immunosurveillance and Future Senescence-Induced Therapy in Hepatocellular Carcinoma","volume":"10","author":"Liu","year":"2020","journal-title":"Front Oncol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.21037\/atm-20-4733","article-title":"Protein Tyrosine Phosphatase Receptor Type D (PTPRD)-Mediated Signaling Pathways for the Potential Treatment of Hepatocellular Carcinoma: A Narrative Review","volume":"8","author":"Huang","year":"2020","journal-title":"Ann Trans Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2019.00369","article-title":"Targeting PIN1 as a Therapeutic Approach for Hepatocellular Carcinoma","volume":"7","author":"Cheng","year":"2019","journal-title":"Front Cell Dev Biol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.548335","article-title":"Recent Advances in Liver Cancer Stem Cells: Non-Coding RNAs, Oncogenes and Oncoproteins","volume":"8","author":"Li","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"553","DOI":"10.21037\/atm.2020.02.116","article-title":"Prognostic Value of the Albumin-Bilirubin Grade in Patients With Hepatocellular Carcinoma and Other Liver Diseases","volume":"8","author":"Feng","year":"2020","journal-title":"Ann Trans Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00780","article-title":"Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma","volume":"10","author":"Li","year":"2020","journal-title":"Front Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.21037\/atm-20-2554a","article-title":"The Role of Ferroptosis Regulators in the Prognosis, Immune Activity and Gemcitabine Resistance of Pancreatic Cancer","volume":"8","author":"Tang","year":"2020","journal-title":"Ann Trans Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.592413","article-title":"Ubiquitin-Like Modifier Activating Enzyme 1 as a Novel Diagnostic and Prognostic Indicator That Correlates With Ferroptosis and the Malignant Phenotypes of Liver Cancer Cells","volume":"10","author":"Shan","year":"2020","journal-title":"Front Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-020-00644-4","article-title":"Branched-Chain Amino Acid Aminotransferase 2 Regulates Ferroptotic Cell Death in Cancer Cells","volume":"28","author":"Wang","year":"2021","journal-title":"Cell Death Differ"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.596679","article-title":"Development and Validation of a Combined Ferroptosis and Immune Prognostic Classifier for Hepatocellular Carcinoma","volume":"8","author":"Liu","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.7150\/thno.48206","article-title":"Integrative Analysis of Long Extracellular RNAs Reveals a Detection Panel of Noncoding RNAs for Liver Cancer","volume":"11","author":"Zhu","year":"2021","journal-title":"Theranostics"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-019-0839-x","article-title":"M6A-Mediated Upregulation of LINC00958 Increases Lipogenesis and Acts as a Nanotherapeutic Target in Hepatocellular Carcinoma","volume":"13","author":"Zuo","year":"2020","journal-title":"J Hematol Oncol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"16185","DOI":"10.1038\/s41598-019-52837-8","article-title":"LncRNA GABPB1-AS1 and GABPB1 Regulate Oxidative Stress During Erastin-Induced Ferroptosis in HepG2 Hepatocellular Carcinoma Cells","volume":"9","author":"Qi","year":"2019","journal-title":"Sci Rep"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.45050","article-title":"A Novel Ferroptosis-Related Gene Signature for Overall Survival Prediction in Patients With Hepatocellular Carcinoma","volume":"16","author":"Liang","year":"2020","journal-title":"Int J Biol Sci"},{"key":"B15","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s11357-020-00182-4","article-title":"Developmental Exposure to Cannabidiol (CBD) Alters Longevity and Health Span of Zebrafish (Danio Rerio)","volume":"42","author":"Pandelides","year":"2020","journal-title":"GeroScience"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-020-00196-y","article-title":"Angiotensin (1-7) Delivered Orally via Probiotic, But Not Subcutaneously, Benefits the Gut-Brain Axis in Older Rats","volume":"42","author":"Buford","year":"2020","journal-title":"GeroScience"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-019-00095-x","article-title":"Nicotinamide Mononucleotide (NMN) Supplementation Promotes Anti-Aging miRNA Expression Profile in the Aorta of Aged Mice, Predicting Epigenetic Rejuvenation and Anti-Atherogenic Effects","volume":"41","author":"Kiss","year":"2019","journal-title":"GeroScience"},{"key":"B18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v033.i01","article-title":"Regularization Paths for Generalized Linear Models via Coordinate Descent","volume":"33","author":"Friedman","year":"2010","journal-title":"J Stat Softw"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/sim.5958","article-title":"Estimating and Comparing Time-Dependent Areas Under Receiver Operating Characteristic Curves for Censored Event Times With Competing Risks","volume":"32","author":"Blanche","year":"2013","journal-title":"Stat Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1177\/1740774520905563","article-title":"Designing Clinical Trials With (Restricted) Mean Survival Time Endpoint: Practical Considerations","volume":"17","author":"Eaton","year":"2020","journal-title":"Clin Trials"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.3337","article-title":"Robust Enumeration of Cell Subsets From Tissue Expression Profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat Methods"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2020.1830524","article-title":"Converging Focal Radiation and Immunotherapy in a Preclinical Model of Triple Negative Breast Cancer: Contribution of VISTA Blockade","volume":"9","author":"Pilones","year":"2020","journal-title":"Oncoimmunology"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-2428","article-title":"Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy","volume":"22","author":"Picarda","year":"2016","journal-title":"Clin Cancer Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0506580102","article-title":"Gene Set Enrichment Analysis: A Knowledge-Based Approach for Interpreting Genome-Wide Expression Profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110282","article-title":"Solasonine Promotes Ferroptosis of Hepatoma Carcinoma Cells via Glutathione Peroxidase 4-Induced Destruction of the Glutathione Redox System","volume":"129","author":"Jin","year":"2020","journal-title":"Biomed Pharmacother = Biomed Pharmacother"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.101942","article-title":"Quiescin Sulfhydryl Oxidase 1 Promotes Sorafenib-Induced Ferroptosis in Hepatocellular Carcinoma by Driving EGFR Endosomal Trafficking and Inhibiting NRF2 Activation","volume":"41","author":"Sun","year":"2021","journal-title":"Redox Biol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00280-020-04170-5","article-title":"Artemisinin-Type Drugs for the Treatment of Hematological Malignancies","volume":"87","author":"Mancuso","year":"2021","journal-title":"Cancer Chemother Pharmacol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1109427108","article-title":"Crucial Role for TNF Receptor-Associated Factor 2 (TRAF2) in Regulating NFkappaB2 Signaling That Contributes to Autoimmunity","volume":"108","author":"Lin","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00630","article-title":"Digitoxin Inhibits Epithelial-To-Mesenchymal-Transition in Hereditary Castration Resistant Prostate Cancer","volume":"9","author":"Pollard","year":"2019","journal-title":"Front Oncol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2019.1710063","article-title":"Therapeutic Melanoma Vaccine With Cancer Stem Cell Phenotype Represses Exhaustion and Maintains Antigen-Specific T Cell Stemness by Up-Regulating BCL6","volume":"9","author":"Czerwinska","year":"2020","journal-title":"Oncoimmunology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e23154","DOI":"10.4161\/jkst.23154","article-title":"Interleukin-2 and STAT5 in Regulatory T Cell Development and Function","volume":"2","author":"Mahmud","year":"2013","journal-title":"Jak-Stat"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31840","article-title":"Mechanistic Rationales Guiding Combination Hepatocellular Carcinoma Therapies Involving Immune Checkpoint Inhibitors","author":"Wing-Sum Cheu","year":"2021","journal-title":"Hepatology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"eaaz6804","DOI":"10.1126\/scitranslmed.aaz6804","article-title":"A Selective HDAC8 Inhibitor Potentiates Antitumor Immunity and Efficacy of Immune Checkpoint Blockade in Hepatocellular Carcinoma","volume":"13","author":"Yang","year":"2021","journal-title":"Sci Trans Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"114285","DOI":"10.1016\/j.bcp.2020.114285","article-title":"A nine-lncRNA Signature Predicts Distant Relapse-Free Survival of HER2-Negative Breast Cancer Patients Receiving Taxane and Anthracycline-Based Neoadjuvant Chemotherapy","volume":"189","author":"Sun","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.21037\/atm-20-922","article-title":"Identification of Molecular Features Correlating With Tumor Immunity in Gastric Cancer by Multi-Omics Data Analysis","volume":"8","author":"He","year":"2020","journal-title":"Ann Trans Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v25.i2.220","article-title":"Six-Long non-Coding RNA Signature Predicts Recurrence-Free Survival in Hepatocellular Carcinoma","volume":"25","author":"Gu","year":"2019","journal-title":"World J Gastroenterol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.29730","article-title":"Immune-Related Long Noncoding RNA Signature for Predicting Survival and Immune Checkpoint Blockade in Hepatocellular Carcinoma","volume":"235","author":"Zhang","year":"2020","journal-title":"J Cell Physiol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1007\/s10120-018-00911-x","article-title":"Prognostic and Clinicopathological Significance of Long Noncoding RNA CTD-2510F5.4 in Gastric Cancer","volume":"22","author":"Wang","year":"2019","journal-title":"Gastric Cancer"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2019.05.042","article-title":"Long Noncoding RNA DDX11-AS1 Epigenetically Represses LATS2 by Interacting With EZH2 and DNMT1 in Hepatocellular Carcinoma","volume":"514","author":"Li","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2019.10.007","article-title":"Silencing Long Non-Coding RNA LINC01224 Inhibits Hepatocellular Carcinoma Progression via MicroRNA-330-5p-Induced Inhibition of CHEK1","volume":"19","author":"Gong","year":"2020","journal-title":"Mol Ther Nucleic Acids"},{"key":"B41","doi-asserted-by":"publisher","first-page":"124","DOI":"10.21037\/atm.2020.02.36","article-title":"Expression and Prognostic Potential of GPX1 in Human Cancers Based on Data Mining","volume":"8","author":"Wei","year":"2020","journal-title":"Ann Trans Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"675","DOI":"10.21037\/atm-21-997","article-title":"Ferroptosis Is Involved in the Progression of Hepatocellular Carcinoma Through the Circ0097009\/miR-1261\/SLC7A11 Axis","volume":"9","author":"Lyu","year":"2021","journal-title":"Ann Trans Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41420-021-00468-2","article-title":"O-GlcNAcylation Enhances Sensitivity to RSL3-Induced Ferroptosis via the YAP\/TFRC Pathway in Liver Cancer","volume":"7","author":"Zhu","year":"2021","journal-title":"Cell Death Discov"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2020.07.013","article-title":"The Progress and Perspective of Nanoparticle-Enabled Tumor Metastasis Treatment","volume":"10","author":"Zhang","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2020.07.003","article-title":"The Role of Lysosome in Regulated Necrosis","volume":"10","author":"Alu","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.21037\/atm-20-3378","article-title":"Immune Checkpoint Inhibitor in Liver Cancer-Unique Regional Differences","volume":"8","author":"Obi","year":"2020","journal-title":"Ann Trans Med"},{"key":"B47","doi-asserted-by":"publisher","first-page":"528","DOI":"10.21037\/atm.2019.09.122","article-title":"Clinical Significance of the Immune Cell Landscape in Hepatocellular Carcinoma Patients With Different Degrees of Fibrosis","volume":"7","author":"Tang","year":"2019","journal-title":"Ann Trans Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30528","article-title":"An Efficient Combination Immunotherapy for Primary Liver Cancer by Harmonized Activation of Innate and Adaptive Immunity in Mice","volume":"69","author":"Wen","year":"2019","journal-title":"Hepatology"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.650486","article-title":"In Situ Vaccination as a Strategy to Modulate the Immune Microenvironment of Hepatocellular Carcinoma","volume":"12","author":"Lurje","year":"2021","journal-title":"Front Immunol"},{"key":"B50","article-title":"Follicular Helper T Cell Exhaustion Induced by PD-L1 Expression in Hepatocellular Carcinoma Results in Impaired Cytokine Expression and B Cell Help, and Is Associated With Advanced Tumor Stages","volume":"8","author":"Zhou","year":"2016","journal-title":"Am J Trans Res"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.719175\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T04:38:17Z","timestamp":1631853497000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.719175\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,17]]},"references-count":50,"alternative-id":["10.3389\/fimmu.2021.719175"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.719175","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,17]]},"article-number":"719175"}}